DarioHealth (NASDAQ:DRIO) Stock Crosses Below 200 Day Moving Average – What’s Next?

Shares of DarioHealth Corp. (NASDAQ:DRIO) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.73 and traded as low as $0.64. DarioHealth shares last traded at $0.66, with a volume of 65,669 shares changing hands.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on DRIO shares. Stifel Nicolaus reduced their target price on DarioHealth from $3.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, March 11th. TD Cowen lowered DarioHealth from a “buy” rating to a “hold” rating and reduced their price objective for the company from $2.00 to $1.00 in a report on Wednesday, January 29th.

DarioHealth Trading Up 0.8%

The firm has a fifty day simple moving average of $0.68 and a two-hundred day simple moving average of $0.73. The firm has a market capitalization of $27.43 million, a P/E ratio of -0.70 and a beta of 1.55. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32.

DarioHealth (NASDAQ:DRIO) last announced its quarterly earnings data on Wednesday, May 14th. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.07). DarioHealth had a negative net margin of 205.62% and a negative return on equity of 72.16%. The firm had revenue of $6.75 million for the quarter, compared to the consensus estimate of $7.48 million. During the same period last year, the company posted $0.05 earnings per share. On average, equities research analysts anticipate that DarioHealth Corp. will post -1.18 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DarioHealth

An institutional investor recently raised its position in DarioHealth stock. DLK Investment Management LLC raised its position in shares of DarioHealth Corp. (NASDAQ:DRIO) by 40.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 141,657 shares of the company’s stock after purchasing an additional 41,107 shares during the period. DLK Investment Management LLC owned 0.42% of DarioHealth worth $111,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 33.39% of the company’s stock.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.